INS and diabetes mellitus: The patient’s postoperative course was uneventful, and he was discharged 27 days after surgery with self-injectable long-acting insulin (4 units/day) for DM and pancrelipase 900 mg per day for replacement therapy for pancreatic exocrine insufficiency.